메뉴 건너뛰기




Volumn 259, Issue SUPPL. 2, 2009, Pages

Cognitive behavioural treatment of negative symptoms in schizophrenia patients: Study design of the TONES study, feasibility and safety of treatment

Author keywords

Cognitive behavioural therapy; Negative symptoms; Randomised clinical trial; Schizophrenia

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOTHERAPIST; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 73449109885     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-009-0047-8     Document Type: Article
Times cited : (24)

References (23)
  • 1
    • 0029895049 scopus 로고    scopus 로고
    • A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale
    • DOI 10.1016/0920-9964(95)00070-4
    • D Addington J Addington M Atkinson 1996 A psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale Schizophr Res 19 205 212 10.1016/0920-9964(95)00070-4 1:STN:280: DyaK28zotF2jtA%3D%3D 8789919 (Pubitemid 26180488)
    • (1996) Schizophrenia Research , vol.19 , Issue.2-3 , pp. 205-212
    • Addington, D.1    Addington, J.2    Atkinson, M.3
  • 2
    • 1642283731 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with schizophrenia
    • American Psychiatric Association 2nd edn. (Suppl Feb)
    • American Psychiatric Association (2004) Practice guideline for the treatment of patients with schizophrenia, 2nd edn. Am J Psychiatry 161(Suppl Feb)
    • (2004) Am J Psychiatry 161
  • 3
    • 0035207295 scopus 로고    scopus 로고
    • Die wirksamkeit individualisierter kognitiver verhaltenstherapie bei schizophrener negativsymptomatik und sozialer behinderung: Eine kontrollierte studie
    • DOI 10.1026//1616-3443.30.4.268
    • J Bailer I Takats C Westermeier 2001 Die Wirksamkeit individualisierter Kognitiver Verhaltenstherapie bei schizophrener Negativsymptomatik und sozialer Behinderung: Eine kontrollierte Studie Z Klin Psychol Psychother 30 268 278 10.1026//1616-3443.30.4.268 (Pubitemid 33140716)
    • (2001) Zeitschrift fur Klinische Psychologie und Psychotherapie , vol.30 , Issue.4 , pp. 268-278
    • Bailer, J.1    Takats, I.2    Westermeier, C.3
  • 4
    • 0031938219 scopus 로고    scopus 로고
    • A group cognitive-behavioral and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness
    • 1:STN:280:DyaK1c7ovVersg%3D%3D 9527960
    • L Daniels 1998 A group cognitive-behavioral and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness J Psychother Pract Res 7 167 176 1:STN:280:DyaK1c7ovVersg%3D%3D 9527960
    • (1998) J Psychother Pract Res , vol.7 , pp. 167-176
    • Daniels, L.1
  • 5
    • 0038653525 scopus 로고    scopus 로고
    • A meta-analysis of the efficacy of second-generation antipsychotics
    • DOI 10.1001/archpsyc.60.6.553
    • JM Davis N Chen ID Glick 2003 A meta-analysis of the efficacy of second-generation antipsychotics Arch Gen Psychiatry 60 553 564 10.1001/archpsyc.60.6.553 1:CAS:528:DC%2BD3sXltlKhtrc%3D 12796218 (Pubitemid 36682312)
    • (2003) Archives of General Psychiatry , vol.60 , Issue.6 , pp. 553-564
    • Davis, J.M.1    Chen, N.2    Glick, I.D.3
  • 6
    • 0037400950 scopus 로고    scopus 로고
    • The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis
    • DOI 10.1016/S0920-9964(02)00302-X
    • R Emsley J Rabinowitz M Torreman 2003 The factor structure for the positive and negative syndrome scale (PANSS) in recent-onset psychosis Schizophr Res 61 47 57 10.1016/S0920-9964(02)00302-X 12648735 (Pubitemid 36332139)
    • (2003) Schizophrenia Research , vol.61 , Issue.1 , pp. 47-57
    • Emsley, R.1    Rabinowitz, J.2    Torreman, M.3    Schooler, N.4    Kapala, L.5    Davidson, M.6    McGory, P.7
  • 7
    • 41549116886 scopus 로고    scopus 로고
    • A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: Focus on somnolence
    • 10.4088/JCP.v69n0217 1:CAS:528:DC%2BD1cXktVWrsb8%3D 18211129
    • K Gao SJ Ganocy P Gajwani DJ Muzina DE Kemp JR Calabrese 2008 A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence J Clin Psychiatry 69 302 309 10.4088/JCP.v69n0217 1:CAS:528:DC%2BD1cXktVWrsb8%3D 18211129
    • (2008) J Clin Psychiatry , vol.69 , pp. 302-309
    • Gao, K.1    Ganocy, S.J.2    Gajwani, P.3    Muzina, D.J.4    Kemp, D.E.5    Calabrese, J.R.6
  • 8
    • 0034029845 scopus 로고    scopus 로고
    • Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"?
    • 1:STN:280:DC%2BD3c3hs1Cnuw%3D%3D 10755673
    • MF Green RS Kern DL Braff J Mintz 2000 Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 26 119 136 1:STN:280:DC%2BD3c3hs1Cnuw%3D%3D 10755673
    • (2000) Schizophr Bull , vol.26 , pp. 119-136
    • Green, M.F.1    Kern, R.S.2    Braff, D.L.3    Mintz, J.4
  • 9
    • 0032781706 scopus 로고    scopus 로고
    • Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia
    • 10.1111/j.1600-0447.1999.tb10831.x 10480196
    • H Häfner W Löffler K Maurer M Hambrecht W an der Heiden 1999 Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia Acta Psychiatr Scand 100 105 118 10.1111/j.1600-0447. 1999.tb10831.x 10480196
    • (1999) Acta Psychiatr Scand , vol.100 , pp. 105-118
    • Häfner, H.1    Löffler, W.2    Maurer, K.3    Hambrecht, M.4    An Der Heiden, W.5
  • 10
    • 0031903740 scopus 로고    scopus 로고
    • Neurocognitive deficit in schizophrenia: A quantitative review of the evidence
    • DOI 10.1037/0894-4105.12.3.426
    • RW Heinrichs KK Zakzanis 1998 Neurocognitive deficit in schizophrenia: a quantitative review of the evidence Neuropsychology 12 426 445 10.1037/0894-4105.12.3.426 1:STN:280:DyaK1czjvVOrtA%3D%3D 9673998 (Pubitemid 28323862)
    • (1998) Neuropsychology , vol.12 , Issue.3 , pp. 426-445
    • Heinrichs, R.W.1    Zakzanis, K.K.2
  • 11
    • 0035183910 scopus 로고    scopus 로고
    • Longitudinal assessment of negative symptoms in schizophrenia/ schizoaffective patients, other psychotic patients, and depressed patients
    • 1:STN:280:DC%2BD3MrltVamsg%3D%3D 11596853
    • ES Herbener M Harrow 2001 Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients Schizophr Bull 27 527 537 1:STN:280:DC%2BD3MrltVamsg%3D%3D 11596853
    • (2001) Schizophr Bull , vol.27 , pp. 527-537
    • Herbener, E.S.1    Harrow, M.2
  • 14
    • 33845897610 scopus 로고    scopus 로고
    • Disorganization and cognitive impairment in schizophrenia: Independent symptom dimensions?
    • DOI 10.1007/s00406-006-0704-0
    • S Klingberg A Wittorf G Wiedemann 2006 Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions? Eur Arch Psychiatry Clin Neurosci 256 532 540 10.1007/s00406-006-0704-0 17164977 (Pubitemid 46020527)
    • (2006) European Archives of Psychiatry and Clinical Neuroscience , vol.256 , Issue.8 , pp. 532-540
    • Klingberg, S.1    Wittorf, A.2    Wiedemann, G.3
  • 17
    • 73449133263 scopus 로고    scopus 로고
    • Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care (update)
    • National Institute for Health and Clinical Excellence National Institute for Health and Clinical Excellence, London
    • National Institute for Health and Clinical Excellence (2009) Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). National Clinical Practice Guideline Number 82. National Institute for Health and Clinical Excellence, London
    • (2009) National Clinical Practice Guideline Number 82
  • 18
    • 2342511506 scopus 로고    scopus 로고
    • Supportive therapy for schizophrenia: Possible mechanisms and implications for adjunctive psychosocial treatments
    • 15176765
    • DL Penn KT Mueser N Tarrier A Gloege C Cather D Serrano MW Otto 2004 Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments Schizophr Bull 30 101 112 15176765
    • (2004) Schizophr Bull , vol.30 , pp. 101-112
    • Penn, D.L.1    Mueser, K.T.2    Tarrier, N.3    Gloege, A.4    Cather, C.5    Serrano, D.6    Otto, M.W.7
  • 19
    • 0033864933 scopus 로고    scopus 로고
    • Differentiating primary from secondary negative symptoms in schizophrenia: A study of neuroleptic-naive patients before and after treatment
    • DOI 10.1176/appi.ajp.157.9.1461
    • V Peralta MJ Cuesta A Martinez Larrea JF Serrano 2000 Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment Am J Psychiatry 157 1461 1466 10.1176/appi.ajp.157.9.1461 1:STN:280:DC%2BD3cvktFClsg%3D%3D 10964863 (Pubitemid 30677139)
    • (2000) American Journal of Psychiatry , vol.157 , Issue.9 , pp. 1461-1466
    • Peralta, V.1    Cuesta, M.J.2    Martinez-Larrea, A.3    Serrano, J.F.4
  • 20
    • 33645367547 scopus 로고    scopus 로고
    • Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBT
    • 10.1016/j.schres.2005.12.846 16460916
    • N Tarrier G Haddock S Lewis R Drake L Gregg 2006 Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT Schizophr Res 83 15 27 10.1016/j.schres.2005.12.846 16460916
    • (2006) Schizophr Res , vol.83 , pp. 15-27
    • Tarrier, N.1    Haddock, G.2    Lewis, S.3    Drake, R.4    Gregg, L.5
  • 22
    • 28244463270 scopus 로고    scopus 로고
    • Remediation of impairments in facial affect recognition in schizophrenia: Efficacy and specificity of a new training program
    • DOI 10.1016/j.schres.2005.07.018, PII S0920996405003063
    • W Wölwer N Frommann S Halfmann A Piaszek M Streit W Gaebel 2005 Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program Schizophr Res 80 295 303 10.1016/j.schres.2005.07.018 16125367 (Pubitemid 41713655)
    • (2005) Schizophrenia Research , vol.80 , Issue.2-3 , pp. 295-303
    • Wolwer, W.1    Frommann, N.2    Halfmann, S.3    Piaszek, A.4    Streit, M.5    Gaebel, W.6
  • 23
    • 44949167544 scopus 로고    scopus 로고
    • Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor
    • 10.1093/schbul/sbm114 17962231
    • T Wykes C Steel B Everitt N Tarrier 2008 Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor Schizophr Bull 34 523 537 10.1093/schbul/sbm114 17962231
    • (2008) Schizophr Bull , vol.34 , pp. 523-537
    • Wykes, T.1    Steel, C.2    Everitt, B.3    Tarrier, N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.